• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > First patient treated for APDS, a rare inherited disorder identified by collaborative Cambridge team including Roger Williams’s group

First patient treated for APDS, a rare inherited disorder identified by collaborative Cambridge team including Roger Williams’s group

First patient treated for APDS, a rare inherited disorder identified by collaborative Cambridge team including Roger Williams’s group

Published on 27 June, 2025

In 2013, Roger Williams’s group in the LMB’s PNAC Division published findings from a study conducted with researchers at the University of Cambridge, the Babraham Institute and clinicians from Addenbrooke’s Hospital. Together, the team identified a rare genetic mutation which causes a condition now known as Activated PI3K-d Syndrome (APDS), which weakens the immune system […]

HR Advisors Ash Munday, Christina Karikides and Callum Armstrong reflect on earning their CIPD Diplomas

Published on 24 June, 2025

The HR Advisors share their motivations and experience of coordinating pursuing the CIPD qualification studies with their job.

Kelly Nguyen awarded 2025 Lister Prize

Published on 19 June, 2025

Kelly Nguyen, Group Leader in the LMB’s Structural Studies Division, has been announced as one of the 2025 recipients of the prestigious Lister Institute Research Prize.

Sortera Bio has raised £7.5m pre-seed investment from AstraZeneca, BioNTech and CIC

Published on 10 June, 2025

Business Weekly reports that Sortera Bio, an LMB spinout company, has attracted backers for a £7.5m pre-seed round to power AI models for drug discovery. The round was led by Cambridge Innovation Capital (CIC) with participation from AstraZeneca and BioNTech. More…

The LMB licences ‘tRNA Display’ technology to Constructive.Bio

Published on 6 June, 2025

Business Weekly reports that Constructive.Bio, an LMB spinout company based on Jason Chin’s research, now holds the exclusive licence to ‘tRNA Display’ technology. The company can start a full commercial rollout of its platform – enabling next-gen synthetic protein engineering applications for pharma, agriculture and advanced materials. More…

Tanmay Bharat awarded EMBO Gold Medal

Published on 5 June, 2025

Tanmay Bharat, Group Leader in the LMB’s Structural Studies Division, received EMBO’s Gold Medal in recognition of his work on prokaryotic surface molecules.

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 320
  • Go to Next Page »

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed.